WITHOUT BREAST CANCER TRIALS, 1000s OF LIVES WOULD BE LOST.

The Australian Centre for Philanthropy and Nonprofit Studies, Queensland University of Technology (QUT), studied the impact of the Breast Cancer Trials research program. The independent report has proven something our researchers, trial participants and everyone involved has known for years — that clinical trials save lives.

scroll to learn more about the impact of breast cancer trials

Play Video

IMPACT:

Thousands

of lives saved

The report found our research has helped provide evidence which guides treatments for patients and improves quality of life. And this all adds up to more lives saved than ever before.

Thanks to worldwide efforts, today 90% of people are alive five years after a breast cancer diagnosis.

That means more women recovering from breast cancer, more women getting to see their children grow up, and more women living long and happy lives.

Play Video

"I can't thank you enough. You gave me a chance at life I didn't think I was going to get."

Nicola, Breast Cancer Patient

From The Report

The findings of this study provide evidence that Breast Cancer Trials is creating substantial impact in the management and treatment of breast cancer, which is benefitting patients in Australia, New Zealand and worldwide.
tamoxifen Letrozole
tamoxifen Letrozole
herceptin Goserelin
herceptin Goserelin
exemestane letrozole
exemestane letrozole

Impact: New

treatments

& prevention

The results from our clinical trials inform and change routine care. This makes it possible to provide new treatments and prevention options for breast cancer patients today — helping to save and improve lives.

Because breast cancer isn’t the same in every person, it’s vital we find tailored treatments and adopt a whole person approach — seeking to improve and protect quality of life, as well as emotional wellbeing.

From The Report

Each year, Breast Cancer Trials publications are highly cited, over 10 times the world benchmark.

Highly cited publications are considered to be indicators of scientific excellence and this means researchers and clinicians around the world are regularly reviewing 
Breast Cancer Trials research results and using it to improve their knowledge and practice.

"I remember when I would see patients who had HER2 positive breast cancer and many would die because we had few treatment options for them.

But since Herceptin, that's dramatically changed.

Knowing that you can help these women today and that most will survive is fantastic.”

Associate Professor Nicholas Wilcken, Breast Cancer Trials Researcher

"I remember when I would see patients who had HER2 positive breast cancer and many would die because we had few treatment options for them.

But since Herceptin, that's dramatically changed.

Knowing that you can help these women today and that most will survive is fantastic.”

Associate Professor Nicholas Wilcken, Breast Cancer Trials Researcher

Impact:

Accelerating

Progress

We bring together 925 researchers in Australia and New Zealand and work with researchers globally to pool resources, share knowledge, and increase access to trials. Simply put, this allows us to find solutions faster for those in need.

“It’s a real privilege to be able to work with the best people” explains one of our founders Professor Alan Coates AM “whether that be down the hall or on the other side of the world.”

By bringing experts together we ensure the best outcomes for women facing breast cancer. Both today and in the future.

Researchers
0
Hospitals in Australia & New Zealand
0

From The Report

Breast Cancer Trials publications were produced by authors across 53 countries and have been cited in documents from 155 countries, demonstrating the international collaborations and reach of Breast Cancer Trials research program.

Impact: Access

to

Clinical Trials

Our clinical trials can provide patients with access to new breast cancer treatments and strategies not yet widely available. People participate because they may benefit, and because people in the future can benefit from what is learned. The treatments available today are possible because people have participated in clinical trials.

Natasha participated in a trial which she says changed her life. She was worried that chemotherapy may leave her unable to have children but thanks to the new drug she received in the trial to protect her fertility, she now has a healthy son. “It’s awesome to think how many women the trial has helped and will help.”

“I can give back and hopefully help save a woman’s life and make her journey easier.”

Madelaine, Clinical Trial Participant

From The Report

Breast Cancer Trials has played a significant role in improving the public perception of participation in clinical trials by promoting trials, engaging participants, and communicating the outcomes of trials.

Breast Cancer Trials members agree that the outcomes of clinical trials include empowering patients to make better health decisions, ensuring better advice is given to patients, and ensuring the families of patients feel more supported because of clinical trials.

Impact: Return

on Investment

Clinical trials take time and significant funding but they are the proven pathway to change. With the help of our amazing community of supporters and funders we have ensured every dollar is used as efficiently as possible to make a real impact on the lives and futures of every person affected by breast cancer.

From The Report

A Benefit Cost Ratio greater than one demonstrates a positive net return for a research investment, so this finding demonstrates that supporting and investing in breast cancer clinical trials delivers tangible and significant health and social benefits for the community.

An economic analysis of investment showed that there are strong returns from the Breast Cancer Trials research program with a conservative Benefit Cost Ratio of 1.371 and an equivalent value of net health and economic gains created equal to $11.3m annually.

Impact:

Empowering

Doctors

Our goal is to empower doctors so that they can save and improve the lives of their patients. Clinical trials have the biggest impact when the scientific knowledge is brought to the ‘real world’. That’s why we provide critical structures and support for clinical trials that have tangible impacts for breast cancer patients and those at risk.

Professor Bruce Mann, Director of Research at Breast Cancer Trials remembers when breast cancer was treated as one single disease.

He explains that “now it’s seen as multiple diseases that behave differently, that respond to different treatments. It means the treatment we can offer a patient diagnosed today is vastly superior to what we could offer 30 or 40 years ago.”

From The Report

The case studies in this report are further evidence of how Breast Cancer Trials has supported the ability of doctors to offer patients personalised treatment options and consequently better quality of life outcomes.

More than 90% of members reported strong personal relevance to Breast Cancer Trials, feeling a sense of purpose and community.

Read the Impact Report

For over 45 years Breast Cancer Trials has been saving and improving the lives of people affected by breast cancer. To learn more about the impact of the clinical trials conducted by Breast Cancer Trials, please download this report.

Donate to Breast Cancer Trials

Sadly, breast cancer still takes lives, ends dreams and reduces quality of life for too many women. Please donate today and help create a future where breast cancer no longer impacts lives.

Sign-up to receive research updates from breast cancer trials

We acknowledge the Traditional Custodians of the lands across Australia and pay respect to Elders past, present and future. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi.

ANZ Breast Cancer Trials Group Limited (trading as Breast Cancer Trials) is registered as a charity with the Australian Charities and Not-For-Profits Commission (ACNC) and a registered tax-exempt charity with DGR (Deductible Gift Recipient) status issued by the Australian Taxation Office, and a member of the Australian Ethical Health Alliance. Donations of $2 or more are tax deductible in Australia.

Download the Impact Report